Trial Profile
Monotherapy With Piperacillin-tazobactam Versus Combination Therapy With Piperacillin-tazobactam Plus Glycopeptide as an Initial Empiric Therapy for Fever in Neutropenic Patients. An Observational Prospective Study.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Feb 2010
Price :
$35
*
At a glance
- Drugs Piperacillin/tazobactam (Primary) ; Glycopeptides
- Indications Bacterial infections; Febrile neutropenia
- Focus Adverse reactions; Therapeutic Use
- Sponsors Wyeth
- 28 Dec 2009 New trial record